Related Experiment Video
Updated: May 26, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Inhibition of the Nedd8 system sensitizes cells to DNA interstrand cross-linking agents
Younghoon Kee1, Min Huang, Sophia Chang
1Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, Florida, USA. Ykee@usf.edu
Abstract:
The Fanconi anemia pathway is required for repair of DNA interstrand cross-links (ICL). Fanconi anemia pathway-deficient cells are hypersensitive to DNA ICL-inducing drugs such as cisplatin. Conversely, hyperactivation of the Fanconi anemia pathway is a mechanism that may underlie cellular resistance to DNA ICL agents. Modulating FANCD2 monoubiquitination, a key step in the Fanconi anemia pathway, may be an effective therapeutic approach to conferring cellular sensitivity to ICL agents. Here, we show that inhibition of the Nedd8 conjugation system increases cellular sensitivity to DNA ICL-inducing agents. Mechanistically, the Nedd8 inhibition, either by siRNA-mediated knockdown of Nedd8-conjugating enzymes or treatment with a Nedd8-activating enzyme inhibitor MLN4924, suppressed DNA damage-induced FANCD2 monoubiquitination and CHK1 phosphorylation. Our data indicate that inhibition of the Fanconi anemia pathway is largely responsible for the heightened cellular sensitivity to DNA ICLs upon Nedd8 inhibition. These results suggest that a combination of Nedd8 inhibition with ICL-inducing agents may be an effective strategy for sensitizing a subset of drug-resistant cancer cells.
Insights
Inhibiting the Nedd8 conjugation system enhances cancer cell sensitivity to DNA interstrand cross-link (ICL) agents by suppressing the Fanconi anemia pathway. This suggests combining Nedd8 inhibitors with ICL drugs could overcome drug resistance.
Area of Science:
- Molecular Biology
- Cancer Biology
- DNA Repair
Background:
- The Fanconi anemia (FA) pathway is crucial for repairing DNA interstrand cross-links (ICLs).
- FA pathway deficiency increases sensitivity to ICL-inducing drugs like cisplatin.
- Hyperactivation of the FA pathway can lead to cellular resistance to ICL agents.
Purpose of the Study:
- To investigate the effect of inhibiting the Nedd8 conjugation system on cellular sensitivity to DNA ICL-inducing agents.
- To explore the underlying mechanisms by which Nedd8 inhibition impacts the Fanconi anemia pathway and DNA damage response.
Main Methods:
- Utilized siRNA-mediated knockdown of Nedd8-conjugating enzymes.
- Administered MLN4924, a Nedd8-activating enzyme inhibitor.
- Assessed DNA damage-induced FANCD2 monoubiquitination and CHK1 phosphorylation.
Main Results:
- Nedd8 inhibition significantly increased cellular sensitivity to DNA ICL-inducing agents.
- Suppression of DNA damage-induced FANCD2 monoubiquitination and CHK1 phosphorylation was observed upon Nedd8 inhibition.
- The heightened sensitivity to ICLs was primarily attributed to the inhibition of the Fanconi anemia pathway.
Conclusions:
- Inhibition of the Nedd8 conjugation system effectively sensitizes cells to DNA ICL-inducing agents.
- Targeting the Nedd8 conjugation system disrupts the Fanconi anemia pathway, a key DNA repair mechanism.
- Combining Nedd8 inhibition with ICL agents presents a potential therapeutic strategy to overcome drug resistance in certain cancer cells.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
Inhibition of Cdk Activity

